Ley et al.

BMC Infectious Diseases 2011, 11:147

http://www.biomedcentral.com/1471-2334/11/147

RESEARCH ARTICLE

Open Access

Assessment and comparative analysis of a rapid

diagnostic test (Tubex) for the diagnosis of
typhoid fever among hospitalized children in
rural Tanzania
Benedikt Ley1,8*, Kamala Thriemer1, Shaali M Ame2, George M Mtove3,4, Lorenz von Seidlein1,4,5, Ben Amos4,6,
Ilse CE Hendriksen4,7, Abraham Mwambuli4, Aikande Shoo4,6, Deok R Kim1, Leon R Ochiai1, Michael Favorov1,
John D Clemens1, Harald Wilfing8, Jacqueline L Deen1,4 and Said M Ali2
Abstract
Background: Typhoid fever remains a significant health problem in many developing countries. A rapid test with a
performance comparable to that of blood culture would be highly useful. A rapid diagnostic test for typhoid fever,
Tubex, is commercially available that uses particle separation to detect immunoglobulin M directed towards
Salmonella Typhi O9 lipopolysaccharide in sera.
Methods: We assessed the sensitivity and specificity of the Tubex test among Tanzanian children hospitalized with
febrile illness using blood culture as gold standard. Evaluation was done considering blood culture confirmed S.
Typhi with non-typhi salmonella (NTS) and non - salmonella isolates as controls as well as with non-salmonella
isolates only.
Results: Of 139 samples tested with Tubex, 33 were positive for S. Typhi in blood culture, 49 were cultureconfirmed NTS infections, and 57 were other non-salmonella infections. Thirteen hemolyzed samples were
excluded. Using all non - S. Typhi isolates as controls, we showed a sensitivity of 79% and a specificity of 89%.
When the analysis was repeated excluding NTS from the pool of controls we showed a sensitivity of 79% and a
specificity of 97%. There was no significant difference in the test performance using the two different control
groups (p > 0.05).
Conclusion: This first evaluation of the Tubex test in an African setting showed a similar performance to those
seen in some Asian settings. Comparison with the earlier results of a Widal test using the same samples showed
no significant difference (p > 0.05) for any of the performance indicators, irrespective of the applied control group.
Keywords: Salmonella, Tubex, Widal, Africa, Rapid Diagnostic Test

Background
Typhoid fever remains a significant health problem in
many developing countries. Estimates suggest an incidence
rate of more than 21.5 million cases globally in the year
2000 [1]. Recent data from Tanzania mainland have found
a strong variation of prevalence rates among blood culture
positive isolates collected in local hospitals, ranging from
* Correspondence: [email protected]
1
Translational Research Division, International Vaccine Institute, Seoul, Korea
Full list of author information is available at the end of the article

9% [2] to 21.4% [3] for Salmonella enterica serovar Typhi

(S. Typhi), no data from Zanzibar are available to date. As
the clinical picture of typhoid fever is often unspecific,
misdiagnosis and insufficient or inadequate treatment are
potential risks associated with the disease. In the absence
of difficult-to-obtain bone marrow specimens, microbiologic culture of a blood sample is considered to be the current state-of-the art test for the diagnosis of typhoid fever
even though its sensitivity may be as low as 40% [4,5]. Culture may take up to seven days and requires a well-run
and equipped laboratory, which is often not available in

2011 Ley et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.

Ley et al. BMC Infectious Diseases 2011, 11:147

http://www.biomedcentral.com/1471-2334/11/147

settings with endemic typhoid fever. The widely in use

Widal test provides a cost efficient alternative [6] for serological diagnosis, however its performance remains unsatisfying with sensitivity reported from Tanzania of 75%
using blood culture as the gold standard and applying a
cut off titer of 1:80 [7]. The test further requires the establishment of a local cut off titer prior to use which is complicated. Therefore, a rapid test with a performance
comparable to that of blood culture would be desirable.
A rapid diagnostic test for typhoid fever, Tubex is
commercially available that uses particle separation to
detect immunoglobulin M (IgM) directed towards Salmonella enterica serovar Typhi (S. Typhi) O9 lipopolysaccharide in patient sera. Performance of the test has
previously been evaluated in a number of studies in Asia
but none in Africa. Using blood culture results for comparison, we assessed the sensitivity and specificity of the
Tubex test among Tanzanian children hospitalized with
febrile illness and compared our results with those from
previous studies.

Methods
For evaluation of the Tubex test, we used a selected
subset of serum samples that was obtained for a fever
surveillance study [2] from Teule Hospital in Muheza
District, Tanzania. In order to accommodate the
required sample size for the test validation, we included
randomly selected and age-matched Salmonella enterica
serotype Typhi (S. Typhi) positive serum samples from a
second fever surveillance study conducted at Chake
Chake Hospital in Pemba, Zanzibar. All samples were
collected from children between the ages of 2 months to
14 years from 2008 to 2009.
At Teule Hospital in Muheza, sera and blood was collected for culture from children with a history of three
days of fever, or a history of less than three days of
fever but with at least one of the following severity criteria: respiratory distress; deep breathing; respiratory
distress in combination with severe pallor; prostration;
capillary refill 3 seconds; temperature gradient; systolic
blood pressure <70 mm Hg; coma defined by Glasgow
Coma Scale (GCS) 10 or Blantyre Coma Scale (BCS)
2; severe jaundice; history of two or more convulsions
in the last 24 hours; blood glucose <3 mmol associated
with clinical signs; neck stiffness; bulging fontanel; or
oxygen saturation <90% [2].
At Chake Chake Hospital in Pemba, sera and blood
was collected for culture from children with a recorded
body temperature of >37.5C for outpatients and any
history of fever for inpatients. Duration of fever was not
considered for study recruitment.
About 3 to 5 milliliters (ml) of blood (depending on
body weight) was collected and inoculated in a BactALERT Pediatric-fan bottle (Teule Hospital) or a

Page 2 of 6

BacTec Peds PLUS /F bottle (Chake Chake Hospital)

and incubated in the respective machine (BacT/ALERT
3D or BacTec 9050). Bacterial growth was evaluated following standard procedures.
The Tubex test (IDL - Sweden) was conducted
according to the manufacturers instructions, which are
as follows. Forty-five microliters (l) of antigen covered
particles were added to the Tubex Reaction Well Strip
and 45 l of non-hemolyzed serum was added. After
two minutes of incubation time, 90 l of magnetic antibody coated solution was added, and the strip was
sealed and shaken for two minutes. The strip was then
placed on a magnetic tray for five minutes, separating
the particles if a positive sample had been added. The
resulting color change of the solution was read and
categorized on a scale from 0 to 10. The results were
interpreted as positive for scores of 4 or greater and as
negative for scores of 2 or below as per the manufacturers instructions. Samples with a color corresponding
to the value of 3 were interpreted as indeterminate. All
blood culture isolates from individuals that matched the
inclusion criteria and that were not considered a contaminant were included in the analysis.
We performed the Tubex test on non-hemolyzed
serum samples from the patients of the two surveillance
studies who had blood culture-confirmed S. Typhi
(defined as group 1), randomly selected cases of nonTyphi serotypes of S. enterica (NTS) (defined as group
2), and randomly selected cases with other (non-Salmonellae) pathogenic bacteria (defined as group 3). Staff
members performing the Tubex test were blinded to the
blood culture results.
For the analysis, sensitivity (true-positive rate) was
defined as the probability that the Tubex test result will
be positive when there is blood culture-confirmed
typhoid fever (group 1) and specificity (true-negative
rate) was defined as the probability that the Tubex test
result will be negative when S. Typhi is not isolated
from blood culture (groups 2 and 3). We conducted a
secondary analysis using only group 3 as the control
group. Comparison of test performance using different
control groups was done using the Yates Chi-Square
Test corrected for continuity.
We conducted a literature review in order to compare
our findings with those from previous studies. We
included studies of the Tubex test, which were identified
by directly searching the MEDLINE database through
PubMed. All articles since the first publication of the
test [8] were included. We also conducted a supplementary search of references in retrieved articles. Abstracts
were reviewed, and if relevant, the article was included.
A comparison of performance of the Tubex test with
earlier published Widal test results obtained from the
same samples was done using McNemars Test for

Ley et al. BMC Infectious Diseases 2011, 11:147

http://www.biomedcentral.com/1471-2334/11/147

Page 3 of 6

Correlated Proportions http://faculty.vassar.edu/lowry/

VassarStats.html.
The fever surveillance studies at Chake-Chake and
Teule Hospitals were approved by their respective local
ethical review boards (Tanzania and Zanzibar), as well
as by the International Vaccine Institutes Institutional
Review Board. Written informed consent was obtained
from legal guardians of all participants prior to any sample or data collection.

Results
A total of 139 samples were tested with Tubex. Thirtythree were found positive for S. Typhi in blood culture
(group 1), 49 were culture-confirmed non-S. Typhi
(NTS) infection (group 2), and 57 were other non-Salmonella infections that were not contaminants (group 3).
Thirteen hemolyzed samples were excluded (Figure 1).
Of the 33 blood culture-positive S. Typhi cases, 26
had a positive Tubex result and were considered as true
positives. Of the 106 blood culture confirmed NTS and
non-salmonella cases (groups 2 and 3), 94 yielded a
negative Tubex result and were considered as true negatives. Considering only the 57 non-Salmonella cases
(group 3) as controls, resulted in 54 true negative cases.
Using groups 2 and 3 as controls showed a sensitivity
of 79% and a specificity of 89% (Table 1). The same

17 serum samples with positive

blood culture results for
Salmonella Typhi from Pemba,
Zanzibar*

Table 1 Performance of Tubex using group 1 as true

positives and two different control groups as true
negatives
Control Group
Sensitivity (95% CI)

Group 2 + 3*

Group 3*

0.79 (0.52-0.81)

0.79 (0.62-0.90)

(absolute numbers)

(26/33)

(26/33)

Specificity (95% CI)

0.89 (0.81-0.94)

0.97 (0.85-0.99)

(absolute numbers)

(94/106)

(94/97)

*Group 1 = S. Typhi (n = 33), Group 2 = all non-yphi Salmonella (n = 49),

Group 3 = all blood culture-positive non-Salmonella cases (n = 57).

analysis was repeated excluding NTS from the pool of

controls and showed 79% and 97% for sensitivity and
specificity, respectively. There was no significant difference in the test performance using the two different
control groups (all were p > 0.05 using the Chi square
test).
A total of 14 articles were retrieved and evaluated for
inclusion into the review. All of the reported studies
were performed in Asia; none in Africa. A total of six
articles were excluded: two evaluated the test for nontyphoidal Salmonella [9] or S. Paratyphi [10], three did
not evaluate the sensitivity and specificity of the test
[11-13], and one was a letter to the editor [14]. Thus,
eight publications were included in the review (Table 2).

189 serum samples with positive blood culture results from Teule

13 excluded (hemolyzed)

54 other bacterial
growth excluded**

33 S. Typhi***
=> group 1

49 Nontyphi
=> group 2

57 other bacterial
growth included**
=> group 3

*Age-matched, randomly selected

**Randomly selected
*** 17 from Zanzibar and 16 from Teule
+
Other bacterial growth included: 11x Escherichia coli, 10x Haemophilus influenzae type B, 8x Streptococcus pneumoniae, 6x Pseudomonas
spp., 5x Acinetobacter baumannii, 3x Streptococcus beta hemolytic group A, 3x Haemophilus influenzae, 2x Staphylcoccus aureus, 1x
Burkholderia cepacia, 1x Streptococcus beta-hemolytic group C , 1x Campylobacter spp., 1x Pateurella multocida, 1x gram negative rods
(not identified further), 1x Citrobacter braakii, 1x Stenotrophomonas, 1x Haemophilus parainfluenzae, 1x Streptococcus beta - hemolytic
Figure 1 Specimen assembly.

Ley et al. BMC Infectious Diseases 2011, 11:147

http://www.biomedcentral.com/1471-2334/11/147

Page 4 of 6

Table 2 Comparison of the performance of the Tubex test from published reports
Year

Journal

Sample
Size

Location

Tubex
cut off

Sens

Spec

True neg.
definition

Reader

Gold
standard

Study
population

Ley, B. et This
al
paper

This
Journal

139

Tanzania

>4

79%

89%

All non-typhi
bacteriamia

Investigator

Blood Culture
(BACTEC)

>2 months +
>37.5
(inpatients) &
history of
fever
(outpatients)

79%

97%

All nonsalmonella
bacteriamia

60%

58%

Other confirmed
bacteremia

ICDDRB lab

Manual Blood
Culture

Active
surveillance
Temp 38C

60%

64%

Blood culture neg

& other
bacteremia
ICDDRB lab,
min. 2
independent
lab techs

Manual Blood
Culture

Outpatients,
all ages with
history of
fever

Author

88

Naheed,
A. et al

Rahman,
M. et al

Dong, B.
et al

2008

2007

2007

Kawano, 2006
R. L. et al

Diagn
Microbiol
Infect Dis.

Diagn
Microbiol
Infect Dis.

Epidemiol.
Infect.

867

243

1732

Bangladesh

Bangladesh

China

>4

91.2% 82.3%

Other febrile
patients

No.
Pos

89.5%

Healthy subjects

100%

43%

Paratyphoid cases

Blood culture
(BACTEC)

Age 5-60
with reported
history of
fever for 3
days

69%

95%

62%

95%

23%

100%

10

15%

100%
Blood culture
neg.

n/A

Manual Blood
Culture
&BACTEC

Clinically
suspected
typhoid cases
Outpatients,
all ages, Pat
with history
of fever for 3
days

JCM.

177

Philippines

94.7% 80.4%

Healthy
subjects

Dutta, S.
et al

2006

Diagn
Microbiol
Infect Dis.

495

India

56%

88%

Paratyphoid and
malaria cases

n/A

Blood Culture
BACTEC

Ohlsen,
S. J. et al

2004

JCM.

79

Vietnam

According
to
protocol

78%

94%

Other labconfirmed febrile

illnesses

n/A

Manual Blood Pat 3 year

Culture/
and history of
BACTEC
4 day fever

House,
D. et al

2001

JCM.

127

Vietnam

>2

87%

76%

Febrile
hospitalized
patients

labtech

Culture

Children and
adults

Lim et al

1998

JCM.

105

Hong
Kong &
Malaysia

>2

100% 100%

Healthy
individuals and
pat with other
bacterial diseases
and autoimmune
disease

labtechs

Culture
confirmed
(56% of pos.),
clinical picture,
various other
tests

Clinical
picture,
culture
confirmed,

Five of the included articles reported findings of test

performance that were similar to our results [15-19].
Two publications showed considerably lower sensitivity
and specificity [20,6], and one reported higher values [8]
(Table 2).

Discussion
We found Tubex has a sensitivity of 79% using either
control group (95%CI: 52-81% for groups 2 and 3, and
62-90% for group 3 only) and a specificity of 89-97%
(95%CI: 81-94% for groups 2 and 3 and 85-99% for

Ley et al. BMC Infectious Diseases 2011, 11:147

http://www.biomedcentral.com/1471-2334/11/147

group 3 only) irrespective of control group. To our

knowledge, this is the first evaluation of the test in an
African population. Our results were similar to those
observed in previous studies (five out of eight studies) in
Asia assessing the performance of the test [15-19],
though Kawano et al. [17] and House et al. [19] used a
lower cut-off titer than is recommended in the manual.
In contrast, two studies [20,6] found the performance of
Tubex to be poorer than our findings, despite using a
similar cut-off value, gold standard, and inclusion criteria. The extremely good performance of Tubex
observed by Lim et al. [8] has not been reproduced
since.
An important limitation of this study is that the sera
are combined from two different patient populations
and the purposeful selection of samples included in the
three groups. During the preparation of the study, we
calculated the sample sizes of true positive sera and true
negative sera that are required for validation of the
Tubex test and for comparison with the Widal test performance. The number of true positive sera from either
hospital alone was insufficient for the validation. Thus,
we included S. Typhi blood culture-confirmed sera from
Pemba. Analysis of the results by hospital was not possible because of insufficient sample size.
In a sub-analysis in assessing cross reactivity with
NTS, blood culture-confirmed NTS cases were considered as true positives, and all other positive isolates,
excluding S. Typhi, were considered as true negatives. In
this sub-analysis Tubex had a sensitivity of 18% and a
specificity of 95% (analysis not shown).
Comparison with a Widal test that was earlier conducted using the same samples [7] revealed no significant difference (p > 0.05) for any of the performance
indicators, irrespective of the applied control group. But
compared to the Widal test, Tubex is easier and quicker
to perform. The Widal test requires 16 - 20 hours until
the results are obtained while the complete procedure
for the Tubex test is approximately 20 minutes. Tubex
is more expensive at approximately 2.15 USD per test
compared to <0.80 USD per test for the Widal tube
agglutination test [6].
Interpreting the Tubex test results was found to be
difficult and the results were prone to inter - reader variation. Assessing the color change according to the provided color scale requires experience and standardized
good lighting conditions. The Tubex test can only be
applied to non-hemolyzed and non-icteric serum samples, thus limiting its general application. However Tam
et al. [12] have described a method that includes a
washing step and thereby addresses the problem of turbid serum. This method requires double the amount of
antigen-coated particles as well as glycine buffered saline
(GBS), thereby increasing the price per sample to

Page 5 of 6

approximately 4.50 USD and reducing its feasibility as

an easy-to-perform test. While neither of the tests can
be performed by untrained staff, interpretation of results
is considered easier for the Widal test compared to
Tubex.

Conclusion
The advantages of Tubex over the Widal test and the
gold standard of blood culture is the short time it
requires to obtain a result, and it does not require establishing a local cut-off value as with the Widal. In settings that can afford the relatively high cost of Tubex
and that require instant individual diagnoses to support
the clinical diagnosis of typhoid fever, Tubex is superior
to the Widal tube agglutination test. For screening and
surveillance purposes, as well as in settings with limited
financial and technical resources, the Widal tube agglutination test is a possible alternative that can provide a
similar performance as Tubex at a lower cost though it
requires more time. Our evaluation of Tubex showed
that any result must be handled with precaution. Results
should be considered as indicative, not confirmatory.
The test may be used to exclude disease though. In conclusion, the need for a reliable, fast, cheap, and easy-toapply rapid diagnostic test for typhoid fever remains in
high demand.
Acknowledgements
We thank Hugh Reyburn of the London School of Hygiene and Tropical
Medicine who supported this project and provided his scientific expertise.
We also thank Rajabu Malahiyo and Steven Magesa for their support.
This work was supported by a grant from the Korea International
Cooperation Agency (KOICA) and the Swedish International Development
Cooperation Agency (SIDA) to the International Vaccine Institute.
This study is published with permission from the Director General of the
Tanzanian National Institute for Medical Research, Dar-Es-Salaam. We are
grateful to the patients and their parents who made this work possible. We
thank all of the technical staff and research assistants who were involved in
the study.
Author details
1
Translational Research Division, International Vaccine Institute, Seoul, Korea.
2
Laboratory Division, Public Health Laboratory (Pemba) - Ivo de Carneri,
Chake Chake, Tanzania. 3Amani Centre, National Institute for Medical
Research, Tanga, Tanzania. 4Joint Malaria Program, Tanga, Tanzania. 5Asia
Pacific Malaria Elimination Network (APMEN), Menzies School of Health
Research, Casuarina, Australia. 6Teule Hospital, Muheza, Tanga, Tanzania.
7
Oxford Research Unit, Mahidol University, Bangkok, Thailand. 8Biocenter,
University of Vienna, Vienna, Austria.
Authors contributions
BL performed the TUBEX test, analyzed results and wrote the manuscript, KT
performed TUBEX tests, literature search and contributed to the manuscript,
SMA supervised the laboratory work in Pemba, GM was in charge of the
implementation and study management in Teule, LvS provided scientific
support to study staff and contributed to the manuscript, BA supervised the
laboratory work in Teule, ICEH was involved in the clinical care of patients,
AM was in charge of data management, AS performed blood culture
procedures, DRK performed statistical analyses, RLO provided scientific
support to the manuscript, MF provided scientific support to the manuscript,
JDC provided scientific support to the manuscript, HW provided scientific
support to the manuscript, JLD provided major scientific support to the

Ley et al. BMC Infectious Diseases 2011, 11:147

http://www.biomedcentral.com/1471-2334/11/147

manuscript and was involved in the clinical care of patients, SMA provided
scientific support to the manuscript and the study in Pemba. All authors
have read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 25 January 2011 Accepted: 24 May 2011
Published: 24 May 2011
References
1. Crump JA, Luby SP, Mintz ED: The global burden of typhoid fever. Bulletin
of the World Health Organization 2004, 82(5):346-353.
2. Mtove G, Amos B, von Seidlein L, Hendriksen I, Mwambuli A, Kimera J,
Mallahiyo R, Kim DR, Ochiai RL, Clemens JD, Reyburn H, Magesa S, Deen JL:
Invasive salmonellosis among children admitted to a rural Tanzanian
hospital and a comparison with previous studies. PLoS One 2010, 5(2):
e9244.
3. Crump JC, Ramadhani HO, Morrisey AB, Saganda W, Mwako MS, Yang LY,
Chow SC, Morpeth SC, Reyburn H, Njau BN, Shaw AV, Diefenthal HC,
Shao JF, Bartett JA, Maro VP: Invasive bacterial and fungal infections
among hospitalized HIV-infected and HIV-uninfected adults and
adolescents in northern Tanzania. CID 2011, 52(3):341-348.
4. Parry CM, Hien TT, Dougan G, White N, Farrar JJ: Typhoid Fever. The New
England Journal of Medicine 2002, 347(22):1770-1782.
5. Wilke A, Ergonul O, Bayar B: Widal Test in Diagnosis of Typhoid Fever in
Turkey. Clin Diagn Lab Immunol 2002, 9(4):938-41.
6. Sur D, Manna B, Sen B, Deb AK, Deen JL, Wain J, von Seidlein L, Ochiai RL,
Clemens JD, Bhattacharya SK: Evaluation of a new-generation serologic
test for the diagnosis of typhoid fever: data from a community - based
surveillance in Calcutta, India. Diagnostic Microbiology and Infectious
Disease 2006, 56:359-365.
7. Ley B, Mtove G, Thriemer K, Amos B, von Seidlein L, Hendriksen I,
Mwambuli A, Shoo A, Malahiyo R, Ame S, Kim DR, Ochiai RL, Clemens JD,
Reyburn H, Wilfing H, Magessa S, Deen JL: Evaluation of the Widal tube
agglutination test for the diagnosis of typhoid fever among children
admitted to a rural hospital in Tanzania and a comparison with previous
studies. BMC 2010, 10:180.
8. Lim PL, Tam FC, Cheong YM, Jegathesan M: One-step 2-minute test to
detect typhoid-specific antibodies based on particle separation in tubes.
J Clin Microbiol 1998, 36(8):2271-8.
9. Oracz G, Feleszko W, Golicka D, Maksymiuk J, Klonowska A, Szajewska H:
Rapid diagnosis of acute Salmonella gastrointestinal infection. Clin Infect
Dis 2003, 36(1):112-5.
10. Tam FC, Wang M, Dong B, Leung DT, Ma CH, Lim PLL: New rapid test for
paratyphoid a fever: usefulness, cross-detection, and solution. Diagn
Microbiol Infect Dis 2008, 62(2):142-50.
11. Tam FC, Lim PL: The TUBEX typhoid test based on particle-inhibition
immunoassay detects IgM but not IgG anti-O9 antibodies. J Immunol
Methods 2003, 282(1-2):83-91.
12. Tam FC, Leung DT, Ma CH, Lim PL: Modification of the TUBEX typhoid
test to detect antibodies directly from haemolytic and whole blood.
Journal of Medical Microbiology 2008, 57:1349-1353.
13. Tam FC, Ling TK, Wong KT, Leung DT, Chan RC, Lim PL: The TUBEX test
detects not only typhoid-specific antibodies but also soluble antigens
and whole bacteria. J Med Microbiol 2008, 57(Pt 3):316-23.
14. Feleszko W, Maksymiuk J, Oracz G, Golicka D, Szajewska H: The TUBEX
typhoid test detects current Salmonella infections. J Immunol Methods
2004, 285(1):137-8.
15. Rahman M, Siddique AK, Tam FC, Sharmin S, Rashid H, Iqbal A, Ahmed S,
Nair GB, Chaignat CL, Lim PL: Rapid detection of early typhoid fever in
endemic community children by the TUBEX O9-antibody test. Diagn
Microbiol Infect Dis 2007, 58(3):275-81.
16. Dong B, Galindo CM, Shin E, Acosta CJ, Page AL, Wang M, Kim D, Ochiai RL,
Park J, Ali M, Seidlein LV, Xu Z, Yang J, Clemens JD: Optimizing typhoid
fever case definitions by combining serological tests in a large
population study in Hechi City, China. Epidemiol Infect 2007, 135(6):1014.
17. Kawano RL, Leano SA, Agdamag DMA: Comparison of serological Test Kits
for Diagnosis of Typhoid Fever in the Philippines. Journal of Clinical
Microbiology 2007, 45(1):246-247.

Page 6 of 6

18. Olsen SJ, Pruckler J, Bibb W, Thanh NTM, Trinh TM, Minh NT,
Sivapalsingam S, Gupta A, Phuong PT, Chinh NT, Chau NV, Cam PD,
Mintz ED: Evaluation of Rapid Diagnostic Test for Typhoid Fever. Journal
of Clinical Microbiology 2004, 42(5):1885-1889.
19. House D, Wain J, Ho VA, Diep TS, Chinh NT, Bay PV, Vinh H, Duc M,
Parry CM, Dougan G, White NJ, Hien TT, Farrar JJ: Serology Of Typhoid
Fever in an Area of Endemicity and Its Relevance to Diagnosis. Journal of
Clinical Microbiology 2001, 39(2):1002-1007.
20. Naheed A, Ram PK, Brooks WA, Mintz ED, Hossain MA, Parsons MM,
Luby SP, Breiman RF: Clinical value of Tubex and Typhidot rapid
diagnostic tests for typhoid fever in an urban community clinic in
Bangladesh. Diagn Microbiol Infect Dis 2008, 61(4):381-6.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/11/147/prepub
doi:10.1186/1471-2334-11-147
Cite this article as: Ley et al.: Assessment and comparative analysis of a
rapid diagnostic test (Tubex) for the diagnosis of typhoid fever
among hospitalized children in rural Tanzania. BMC Infectious Diseases
2011 11:147.

Submit your next manuscript to BioMed Central

and take full advantage of:
Convenient online submission
Thorough peer review
No space constraints or color figure charges
Immediate publication on acceptance
Inclusion in PubMed, CAS, Scopus and Google Scholar
Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit

BioMed Central publishes under the Creative Commons Attribution License (CCAL). Under the CCAL, authors
retain copyright to the article but users are allowed to download, reprint, distribute and /or copy articles in
BioMed Central journals, as long as the original work is properly cited.